|
SEC61A2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.057300E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.685910E-02 |
| Normal-vs-Stage2 |
2.825900E-02 |
| Normal-vs-Stage3 |
4.201600E-03 |
| Normal-vs-Stage4 |
2.157900E-02 |
| Stage1-vs-Stage2 |
6.825000E-01 |
| Stage1-vs-Stage3 |
3.758600E-01 |
| Stage1-vs-Stage4 |
6.167400E-01 |
| Stage2-vs-Stage3 |
8.293400E-01 |
| Stage2-vs-Stage4 |
9.522200E-01 |
| Stage3-vs-Stage4 |
8.834800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.563000E-03 |
| Normal-vs-AfricanAmerican |
1.202010E-01 |
| Normal-vs-Asian |
1.301600E-01 |
| Caucasian-vs-AfricanAmerican |
8.328000E-01 |
| Caucasian-vs-Asian |
3.402200E-01 |
| AfricanAmerican-vs-Asian |
7.037200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.608200E-02 |
| Normal-vs-Female |
1.440740E-03 |
| Male-vs-Female |
1.525180E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.713650E-02 |
| Normal-vs-Age(41-60Yrs) |
5.320900E-03 |
| Normal-vs-Age(61-80Yrs) |
3.829500E-02 |
| Normal-vs-Age(81-100Yrs) |
8.877000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.377800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.018000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.901050E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.334800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.801400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.739800E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.282000E-03 |
| Classical-VS-Follicular |
8.701000E-01 |
| Classical-VS-Other |
8.533600E-01 |
| Classical-VS-Normal |
2.879900E-02 |
| Tall-VS-Follicular |
3.203500E-02 |
| Tall-VS-Other |
2.561200E-01 |
| Tall-VS-Normal |
1.987610E-04 |
| Follicular-VS-Other |
9.071000E-01 |
| Follicular-VS-Normal |
5.433900E-02 |
| Other-VS-Normal |
2.406800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.782700E-03 |
| Normal-vs-N1 |
1.748030E-01 |
| N0-vs-N1 |
4.679400E-01 |
|
|
